Clover Health Investments Corp (CLOV) Investment Overview: Key Insights

A recent SEC filing from Clover Health Investments Corp (NASDAQ: CLOV) disclosed that company officer Jamie Reynoso purchased shares valued at approximately $110,000 on November 4, 2025. The transaction involved buying 30,385 shares at an average price of $3.68 per share.

Following that purchase, Reynoso sold 16,514 shares for total proceeds of around $44,423, with an average selling price of $2.69 per share. After this transaction, the executive now holds 2,955,226 shares of the company.

Prior to these movements, Reynoso had also bought 16,514 shares, a purchase valued at $44,588, at a price of $2.70 per share.

Analyst Ratings and Coverage Updates

In a research report released on December 17, 2024, Craig Hallum initiated coverage on Clover Health with a “Buy” rating and set a $6 price target. Other analysts have also provided updates:

• UBS began covering the stock in October 2024 with a “Neutral” rating.
• Cowen upgraded its view on February 2, 2022, moving from “Underperform” to “Market Perform.”
• Canaccord Genuity also started coverage on February 2, 2022, assigning a “Buy” rating.
• Previously, on January 19, 2022, SVB Leerink initiated coverage with a “Market Perform” rating and a $3 price target.

CLOV Stock Price Performance

As of November 4, 2025, Clover Health Investments Corp shares closed down 4.35%, settling at $3.52. Over the past five trading days, the stock has declined 6.38%.

Year to date, CLOV has fallen 14.56%, though it remains up 11.75% over the past twelve months. The stock reached a 52-week high of $4.87 on January 24, 2025, and a 52-week low of $2.12 on August 8, 2025.

Support and Resistance Levels

Based on the 24-hour chart:

• Support levels: $3.43 (primary), with a potential next level at $3.35 if the first is breached.
• Resistance levels: $3.64 (initial) and $3.77 (secondary).

Short Interest Update

As of October 15, 2025, short interest in CLOV stock rose sharply by about 4.79 million shares, reaching 54.07 million shares in total. The prior month’s short interest (as of September 15, 2025) stood at 49.28 million shares, reflecting an 8.86% inc